title: Clopidogrel and Genotyping.
authors.affiliation: Woodland Clinical Consulting LLC, 5481 S. Acacia Creek Drive, Green Valley, AZ 85622 or Rutgers-RWJ Medical School, New Brunswick, NJ 08903 USA. neville@woodfieldclinical.com.
authors.forename: Neville F
authors.initials: NF
authors.lastname: Ford
mesh_terms: D054058:Acute Coronary Syndrome / Q000235:genetics / Q000378:metabolism / Q000628:therapy*; D000077144:Clopidogrel; D065731:Cytochrome P-450 CYP2C19 / Q000235:genetics*; D004359:Drug Therapy, Combination; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced / Q000235:genetics / Q000517:prevention & control; D005838:Genotype; D006801:Humans; D009853:Omeprazole / Q000627:therapeutic use; D062645:Percutaneous Coronary Intervention; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000493:pharmacokinetics; D012307:Risk Factors; D015607:Stents; D013988:Ticlopidine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000493:pharmacokinetics
chemical_list: D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D065731:Cytochrome P-450 CYP2C19; D009853:Omeprazole; D013988:Ticlopidine